Advertisement
Canada markets closed

  • S&P/TSX

    21,807.37
    +98.93 (+0.46%)
     

  • S&P 500

    4,967.23
    -43.89 (-0.88%)
     

  • DOW

    37,986.40
    +211.02 (+0.56%)
     

  • CAD/USD

    0.7275
    +0.0012 (+0.16%)
     

  • CRUDE OIL

    83.24
    +0.51 (+0.62%)
     

  • Bitcoin CAD

    88,210.30
    +799.92 (+0.92%)
     

  • CMC Crypto 200

    1,381.13
    +68.51 (+5.22%)
     

  • GOLD FUTURES

    2,406.70
    +8.70 (+0.36%)
     

  • RUSSELL 2000

    1,947.66
    +4.70 (+0.24%)
     

  • 10-Yr Bond

    4.6150
    -0.0320 (-0.69%)
     

  • NASDAQ

    15,282.01
    -319.49 (-2.05%)
     

  • VOLATILITY

    18.71
    +0.71 (+3.94%)
     

  • FTSE

    7,895.85
    +18.80 (+0.24%)
     

  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     

  • CAD/EUR

    0.6824
    +0.0003 (+0.04%)
     

Hedge funds' November performance worst since March 2020 - HFR

Reuters
·1 min read
FILE PHOTO: A picture illustration shows U.S. 100 dollar bank notes

LONDON (Reuters) - Hedge funds posted their worst performance in 20 months in November, after a global market selloff sparked by concerns over the Omicron COVID variant, according to data from HedgeFund Research.

Financial markets went into a tailspin in the final week of November with U.S. stocks losing nearly 4% in the last five trading sessions of the month, after news of the variant hit headlines. Currency and bond market volatility also jumped.

The HFRI fund weighted composite Index slipped 2.2% in November, its biggest monthly fall since March 2020, when the coronavirus pandemic first slammed into financial markets, the hedge fund research consultancy said in a report received on Wednesday.

Equity hedge funds which invest in a mix of long and short strategies led broad declines as they were caught off guard by Omicron. The findings echo those of other hedge fund research firms such as PivotalPath.

(Reporting by Saikat Chatterjee; Editing by Sujata Rao)